ArticleAsia-Pacific journal of clinical oncology2026

Real-World Efficacy of Postoperative Adjuvant Nivolumab in High-Risk Urothelial Carcinoma: A Retrospective Comparative Study in an Asian Population.

Ryunosuke Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.